APA (7th ed.) Citation

S, X., LS, S., X, H., V, H., B, H., KJ, B., . . . L, Q. (2026). A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: Application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine. American journal of epidemiology, 195(4), 956. https://doi.org/10.1093/aje/kwaf115

Chicago Style (17th ed.) Citation

S, Xu, Sy LS, Huang X, Hong V, Han B, Bruxvoort KJ, Lewin B, Holmquist KJ, and Qian L. "A Three-part Model for the Self-controlled Case Series Design to Estimate and Characterize Adverse Event Risk in an Overlapping Risk Period After Multiple Vaccines: Application to Ischemic Stroke Following Pfizer-BioNTech Bivalent COVID-19 Vaccine and Influenza Vaccine." American Journal of Epidemiology 195, no. 4 (2026): 956. https://doi.org/10.1093/aje/kwaf115.

MLA (9th ed.) Citation

S, Xu, et al. "A Three-part Model for the Self-controlled Case Series Design to Estimate and Characterize Adverse Event Risk in an Overlapping Risk Period After Multiple Vaccines: Application to Ischemic Stroke Following Pfizer-BioNTech Bivalent COVID-19 Vaccine and Influenza Vaccine." American Journal of Epidemiology, vol. 195, no. 4, 2026, p. 956, https://doi.org/10.1093/aje/kwaf115.